{"id":360339,"date":"2025-08-30T14:06:13","date_gmt":"2025-08-30T14:06:13","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-keros-therapeutics\/"},"modified":"2025-08-30T14:06:13","modified_gmt":"2025-08-30T14:06:13","slug":"how-to-buy-keros-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334036,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-360339","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Keros Therapeutics, Inc. (KROS) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Keros Therapeutics, Inc. (KROS)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Keros Therapeutics, Inc. (KROS) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Keros Therapeutics, Inc. (KROS)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu KROS. Kh\u00e1m ph\u00e1 gi\u00e1 hi\u1ec7n t\u1ea1i, chi\u1ebfn l\u01b0\u1ee3c giao d\u1ecbch v\u00e0 l\u00fd do t\u1ea1i sao c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc n\u00e0y c\u00f3 th\u1ec3 bi\u1ebfn \u0111\u1ed5i danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu KROS. Kh\u00e1m ph\u00e1 gi\u00e1 hi\u1ec7n t\u1ea1i, chi\u1ebfn l\u01b0\u1ee3c giao d\u1ecbch v\u00e0 l\u00fd do t\u1ea1i sao c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc n\u00e0y c\u00f3 th\u1ec3 bi\u1ebfn \u0111\u1ed5i danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c th\u00eam ch\u00fat h\u1ee9ng kh\u1edfi c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u00e0o danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a m\u00ecnh? Keros Therapeutics (KROS) \u0111\u1ea1i di\u1ec7n cho \u0111\u1ec9nh cao c\u1ee7a \u0111\u1ed5i m\u1edbi y h\u1ecdc\u2014nh\u1eafm \u0111\u1ebfn c\u00e1c b\u1ec7nh hi\u1ebfm v\u1edbi khoa h\u1ecdc \u0111\u1ed9t ph\u00e1. C\u00f4ng ty giai \u0111o\u1ea1n l\u00e2m s\u00e0ng n\u00e0y c\u00f3 th\u1ec3 l\u00e0 v\u00e9 c\u1ee7a b\u1ea1n \u0111\u1ebfn t\u0103ng tr\u01b0\u1edfng \u0111\u00e1ng k\u1ec3, nh\u01b0ng ch\u1ec9 khi b\u1ea1n hi\u1ec3u c\u00e1ch \u0111i\u1ec1u h\u01b0\u1edbng c\u00e1c c\u01a1 h\u1ed9i v\u00e0 r\u1ee7i ro \u0111\u1eb7c th\u00f9 c\u1ee7a n\u00f3. H\u00e3y c\u00f9ng ph\u00e2n t\u00edch m\u1ecdi th\u1ee9 b\u1ea1n c\u1ea7n bi\u1ebft \u0111\u1ec3 \u0111\u1ea7u t\u01b0 n\u00e0y ph\u00e1t huy hi\u1ec7u qu\u1ea3 cho b\u1ea1n.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c th\u00eam ch\u00fat h\u1ee9ng kh\u1edfi c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u00e0o danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a m\u00ecnh? Keros Therapeutics (KROS) \u0111\u1ea1i di\u1ec7n cho \u0111\u1ec9nh cao c\u1ee7a \u0111\u1ed5i m\u1edbi y h\u1ecdc\u2014nh\u1eafm \u0111\u1ebfn c\u00e1c b\u1ec7nh hi\u1ebfm v\u1edbi khoa h\u1ecdc \u0111\u1ed9t ph\u00e1. C\u00f4ng ty giai \u0111o\u1ea1n l\u00e2m s\u00e0ng n\u00e0y c\u00f3 th\u1ec3 l\u00e0 v\u00e9 c\u1ee7a b\u1ea1n \u0111\u1ebfn t\u0103ng tr\u01b0\u1edfng \u0111\u00e1ng k\u1ec3, nh\u01b0ng ch\u1ec9 khi b\u1ea1n hi\u1ec3u c\u00e1ch \u0111i\u1ec1u h\u01b0\u1edbng c\u00e1c c\u01a1 h\u1ed9i v\u00e0 r\u1ee7i ro \u0111\u1eb7c th\u00f9 c\u1ee7a n\u00f3. H\u00e3y c\u00f9ng ph\u00e2n t\u00edch m\u1ecdi th\u1ee9 b\u1ea1n c\u1ea7n bi\u1ebft \u0111\u1ec3 \u0111\u1ea7u t\u01b0 n\u00e0y ph\u00e1t huy hi\u1ec7u qu\u1ea3 cho b\u1ea1n."},"body_html":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Keros Therapeutics: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 30 th\u00e1ng 8 n\u0103m 2025, Keros Therapeutics, Inc. (KROS) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>15,48 USD<\/strong>\u2014m\u1ee9c gi\u00e1 \u0111\u00e3 thu h\u00fat s\u1ef1 ch\u00fa \u00fd c\u1ee7a c\u1ea3 nh\u1eefng nh\u00e0 s\u0103n gi\u00e1 tr\u1ecb v\u00e0 nh\u00e0 \u0111\u1ea7u t\u01b0 t\u0103ng tr\u01b0\u1edfng. Nh\u01b0ng h\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: <strong>Ng\u00e0y 5 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 v\u00f4 c\u00f9ng quan tr\u1ecdng. \u0110\u00f3 l\u00e0 khi Keros c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3, v\u00e0 theo l\u1ecbch s\u1eed, c\u00e1c b\u00e1o c\u00e1o n\u00e0y \u0111\u00e3 t\u1ea1o ra nh\u1eefng bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3.<\/p> <h3>C\u00e1ch B\u00e1o C\u00e1o L\u1ee3i Nhu\u1eadn \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu KROS<\/h3> <p>H\u00e3y \u0111\u1ec3 t\u00f4i cho b\u1ea1n th\u1ea5y t\u1ea1i sao l\u1ee3i nhu\u1eadn l\u1ea1i quan tr\u1ecdng \u0111\u1ebfn v\u1eady \u0111\u1ed1i v\u1edbi c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc nh\u01b0 KROS:<\/p> <table> <thead> <tr><th>Ng\u00e0y<\/th><th>S\u1ef1 ki\u1ec7n<\/th><th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th><th>Thay \u0110\u1ed5i Sau Tin<\/th><\/tr> <\/thead> <tbody> <tr><td>6 th\u00e1ng 8, 2025<\/td><td>L\u1ee3i nhu\u1eadn qu\u00fd 2<\/td><td>14,32 USD<\/td><td>+8,1% (v\u01b0\u1ee3t d\u1ef1 b\u00e1o EPS)<\/td><\/tr> <tr><td>7 th\u00e1ng 5, 2025<\/td><td>K\u1ebft qu\u1ea3 qu\u00fd 1<\/td><td>16,50 USD<\/td><td>-12,3% (doanh thu th\u1ea5p h\u01a1n d\u1ef1 ki\u1ebfn)<\/td><\/tr> <tr><td>12 th\u00e1ng 2, 2025<\/td><td>B\u00e1o c\u00e1o h\u00e0ng n\u0103m<\/td><td>18,75 USD<\/td><td>+4,2% (ti\u1ebfn tri\u1ec3n trong pipeline)<\/td><\/tr> <tr><td>5 th\u00e1ng 11, 2024<\/td><td>Qu\u00fd 3 n\u0103m 2024<\/td><td>20,10 USD<\/td><td>-6,8% (tr\u00ec ho\u00e3n l\u00e2m s\u00e0ng)<\/td><\/tr> <tr><td>8 th\u00e1ng 8, 2024<\/td><td>Qu\u00fd 2 n\u0103m 2024<\/td><td>22,40 USD<\/td><td>+3,1% (d\u1eef li\u1ec7u th\u1eed nghi\u1ec7m t\u00edch c\u1ef1c)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Nh\u1eadn \u0110\u1ecbnh Xu H\u01b0\u1edbng<\/strong>: C\u1ed5 phi\u1ebfu Keros ph\u1ea3n \u1ee9ng m\u1ea1nh m\u1ebd v\u1edbi c\u00e1c c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 c\u00e1c c\u1ed9t m\u1ed1c quy \u0111\u1ecbnh. Nh\u1eefng b\u1ea5t ng\u1edd t\u00edch c\u1ef1c c\u00f3 th\u1ec3 k\u00edch ho\u1ea1t bi\u1ebfn \u0111\u1ed9ng 15-20% qua \u0111\u00eam, trong khi th\u1ea5t v\u1ecdng th\u01b0\u1eddng g\u00e2y ra \u0111i\u1ec1u ch\u1ec9nh m\u1ea1nh. \u0110i\u1ec1u then ch\u1ed1t l\u00e0 hi\u1ec3u r\u1eb1ng \u0111\u00e2y kh\u00f4ng ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu blue-chip th\u00f4ng th\u01b0\u1eddng\u2014\u0111\u00e2y l\u00e0 m\u1ed9t tr\u00f2 ch\u01a1i r\u1ee7i ro cao, ph\u1ea7n th\u01b0\u1edfng cao d\u1ef1a tr\u00ean \u0111\u1ed5i m\u1edbi y h\u1ecdc.<\/p> <h3>H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 3 - Th\u00e1ng 8 n\u0103m 2025)<\/h3> <p>C\u1ed5 phi\u1ebfu Keros \u0111\u00e3 tr\u1ea3i qua m\u1ed9t chuy\u1ebfn t\u00e0u l\u01b0\u1ee3n si\u00eau t\u1ed1c:<\/p> <p><strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: 18,20 USD (l\u1ea1c quan sau qu\u00fd 1)<br> <strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: 16,80 USD (th\u1ecb tr\u01b0\u1eddng chung \u0111i\u1ec1u ch\u1ec9nh)<br> <strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: 14,50 USD (doanh thu qu\u00fd 1 th\u1ea5p h\u01a1n k\u1ef3 v\u1ecdng)<br> <strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: 13,25 USD (lo ng\u1ea1i v\u1ec1 ho\u00e0n v\u1ed1n v\u1ed1n)<br> <strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: 15,10 USD (t\u0103ng nh\u1edd kh\u1edfi \u0111\u1ed9ng th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 3)<br> <strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: 15,48 USD (v\u01b0\u1ee3t l\u1ee3i nhu\u1eadn qu\u00fd 2)<\/p> <p>C\u1ed5 phi\u1ebfu \u0111\u00e3 gi\u1ea3m kho\u1ea3ng <strong>15%<\/strong> trong giai \u0111o\u1ea1n n\u00e0y nh\u01b0ng \u0111\u00e3 cho th\u1ea5y d\u1ea5u hi\u1ec7u \u1ed5n \u0111\u1ecbnh trong v\u00e0i tu\u1ea7n g\u1ea7n \u0111\u00e2y. T\u1ea1i sao l\u1ea1i bi\u1ebfn \u0111\u1ed9ng nh\u01b0 v\u1eady? Keros ho\u1ea1t \u0111\u1ed9ng trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1ed1n r\u1ea5t kh\u00f3 \u0111o\u00e1n, n\u01a1i k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng c\u00f3 th\u1ec3 l\u00e0m thay \u0111\u1ed5i gi\u00e1 tr\u1ecb c\u00f4ng ty ch\u1ec9 sau m\u1ed9t \u0111\u00eam.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 ti\u1ebfn tri\u1ec3n l\u00e2m s\u00e0ng, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 mang l\u1ea1i:<\/p> <p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 22-28 USD (ch\u1edd k\u1ebft qu\u1ea3 qu\u00fd 3 v\u00e0 c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m) \u2192 <strong>MUA<\/strong><br> <strong>2026<\/strong>: 35-45 USD (c\u00f3 th\u1ec3 n\u1ed9p h\u1ed3 s\u01a1 FDA cho c\u00e1c \u1ee9ng vi\u00ean h\u00e0ng \u0111\u1ea7u)<br> <strong>2028<\/strong>: 60-80 USD (giai \u0111o\u1ea1n th\u01b0\u01a1ng m\u1ea1i h\u00f3a n\u1ebfu \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t)<br> <strong>2030<\/strong>: Tr\u00ean 100 USD (th\u01b0\u01a1ng hi\u1ec7u b\u1ec7nh hi\u1ebfm \u0111\u00e3 \u0111\u01b0\u1ee3c thi\u1ebft l\u1eadp)<\/p> <p><strong>K\u1ebft lu\u1eadn<\/strong>: \u0110\u00e2y l\u00e0 m\u1ed9t <strong>mua mang t\u00ednh \u0111\u1ea7u c\u01a1<\/strong> d\u00e0nh cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu \u0111\u01b0\u1ee3c r\u1ee7i ro. Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng r\u1ea5t l\u1edbn n\u1ebfu c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng th\u00e0nh c\u00f4ng, nh\u01b0ng c\u0169ng c\u00f3 r\u1ee7i ro th\u1ea5t b\u1ea1i \u0111\u00e1ng k\u1ec3. Ch\u1ec9 n\u00ean \u0111\u1ea7u t\u01b0 s\u1ed1 ti\u1ec1n b\u1ea1n c\u00f3 th\u1ec3 ch\u1ea5p nh\u1eadn m\u1ea5t.<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3> <ul> <li><strong>Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: R\u1ee7i ro l\u1edbn nh\u1ea5t\u2014th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 3 c\u00f3 th\u1ec3 cho th\u1ea5y hi\u1ec7u qu\u1ea3 kh\u00f4ng \u0111\u1ee7 ho\u1eb7c v\u1ea5n \u0111\u1ec1 an to\u00e0n. C\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc c\u00f3 th\u1ec3 gi\u1ea3m 50-80% khi c\u00f3 k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m ti\u00eau c\u1ef1c.<\/li> <li><strong>R\u00e0o c\u1ea3n quy \u0111\u1ecbnh<\/strong>: FDA t\u1eeb ch\u1ed1i ho\u1eb7c y\u00eau c\u1ea7u th\u00eam nghi\u00ean c\u1ee9u c\u00f3 th\u1ec3 tr\u00ec ho\u00e3n th\u01b0\u01a1ng m\u1ea1i h\u00f3a nhi\u1ec1u n\u0103m.<\/li> <li><strong>Ti\u00eau ti\u1ec1n m\u1eb7t<\/strong>: M\u1eb7c d\u00f9 \u0111\u00e3 ho\u00e0n v\u1ed1n g\u1ea7n \u0111\u00e2y, Keros v\u1eabn ti\u00eau ti\u1ec1n \u0111\u1ec3 ph\u00e1t tri\u1ec3n pipeline. H\u1ecd c\u00f3 th\u1ec3 c\u1ea7n c\u00e1c v\u00f2ng g\u1ecdi v\u1ed1n b\u1ed5 sung.<\/li> <li><strong>C\u1ea1nh tranh<\/strong>: C\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn h\u01a1n \u0111ang ph\u00e1t tri\u1ec3n c\u00e1c ch\u1ea5t \u1ee9c ch\u1ebf TGF-\u03b2 t\u01b0\u01a1ng t\u1ef1 c\u00f3 th\u1ec3 ra th\u1ecb tr\u01b0\u1eddng tr\u01b0\u1edbc.<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3> <ul> <li><strong>Chuy\u1ec3n m\u00ecnh ngo\u1ea1n m\u1ee5c<\/strong>: Keros b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn r\u00f2ng <strong>148,5 tri\u1ec7u USD<\/strong> trong qu\u00fd 1 n\u0103m 2025 so v\u1edbi <strong>l\u1ed7 43,1 tri\u1ec7u USD<\/strong> trong qu\u00fd 1 n\u0103m 2024\u2014m\u1ed9t s\u1ef1 chuy\u1ec3n \u0111\u1ed5i t\u00e0i ch\u00ednh ho\u00e0n to\u00e0n (<a href=\"https:\/\/www.marketbeat.com\/earnings\/reports\/2025-8-6-keros-therapeutics-inc-stock\/\">B\u00e1o c\u00e1o L\u1ee3i nhu\u1eadn Qu\u00fd 2<\/a>).<\/li> <li><strong>Ti\u1ebfn tri\u1ec3n giai \u0111o\u1ea1n 3<\/strong>: Vi\u1ec7c kh\u1edfi \u0111\u1ed9ng th\u1eed nghi\u1ec7m RENEW cho th\u1ea5y c\u00f4ng ty \u0111ang th\u1ef1c hi\u1ec7n \u0111\u00fang ti\u1ebfn \u0111\u1ed9 ph\u00e1t tri\u1ec3n.<\/li> <li><strong>Ch\u1ec9 \u0111\u1ecbnh thu\u1ed1c m\u1ed3 c\u00f4i<\/strong>: KER-065 nh\u1eadn \u0111\u01b0\u1ee3c tr\u1ea1ng th\u00e1i qu\u00fd gi\u00e1 n\u00e0y cho b\u1ec7nh lo\u1ea1n d\u01b0\u1ee1ng c\u01a1 Duchenne, mang l\u1ea1i \u0111\u1ed9c quy\u1ec1n th\u1ecb tr\u01b0\u1eddng v\u00e0 l\u1ee3i \u00edch t\u00e0i ch\u00ednh.<\/li> <li><strong>Ni\u1ec1m tin c\u1ee7a nh\u00e0 ph\u00e2n t\u00edch<\/strong>: M\u1eb7c d\u00f9 bi\u1ebfn \u0111\u1ed9ng g\u1ea7n \u0111\u00e2y, m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh l\u00e0 <strong>30,00 USD<\/strong>\u2014g\u1ea7n g\u1ea5p \u0111\u00f4i gi\u00e1 hi\u1ec7n t\u1ea1i (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/KROS\/forecast\/\">D\u1ef1 b\u00e1o c\u1ee7a Nh\u00e0 ph\u00e2n t\u00edch<\/a>).<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 2-3% danh m\u1ee5c \u0111\u1ea7u t\u01b0 cho KROS. \u0110\u00e2y kh\u00f4ng ph\u1ea3i l\u00e0 t\u00ecnh hu\u1ed1ng \"\u0111\u1eb7t c\u01b0\u1ee3c t\u1ea5t c\u1ea3\".<\/li> <li><strong>Trung b\u00ecnh gi\u00e1 theo th\u1eddi gian<\/strong>: Thay v\u00ec mua m\u1ed9t l\u1ea7n, h\u00e3y chia nh\u1ecf c\u00e1c l\u1ea7n mua trong v\u00e0i th\u00e1ng \u0111\u1ec3 gi\u1ea3m r\u1ee7i ro th\u1eddi \u0111i\u1ec3m.<\/li> <li><strong>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7<\/strong>: B\u1ea3o v\u1ec7 b\u1ea3n th\u00e2n v\u1edbi m\u1ee9c d\u1eebng l\u1ed7 15-20% trong tr\u01b0\u1eddng h\u1ee3p th\u1eed nghi\u1ec7m kh\u00f4ng nh\u01b0 \u00fd.<\/li> <li><strong>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc<\/strong>: \"Giao d\u1ecbch KROS gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba\u2014r\u1ea5t th\u00fa v\u1ecb khi m\u1ecdi th\u1ee9 su\u00f4n s\u1ebb, nh\u01b0ng h\u00e3y chu\u1ea9n b\u1ecb cho nh\u1eefng v\u1ee5 n\u1ed5 b\u1ea5t ng\u1edd trong ph\u00f2ng th\u00ed nghi\u1ec7m!\"<\/li> <\/ol> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Keros Therapeutics, Inc. (KROS) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng c\u00f3 truy c\u1eadp NASDAQ v\u00e0 ph\u00ed hoa h\u1ed3ng h\u1ee3p l\u00fd<\/td><\/tr> <tr><td>2<\/td><td>M\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro<\/td><\/tr> <tr><td>3<\/td><td>Nghi\u00ean c\u1ee9u gi\u00e1 hi\u1ec7n t\u1ea1i<\/td><td>Ki\u1ec3m tra gi\u00e1 th\u1eddi gian th\u1ef1c l\u00e0 15,48 USD (t\u00ednh \u0111\u1ebfn 30\/8\/2025)<\/td><\/tr> <tr><td>4<\/td><td>\u0110\u1eb7t l\u1ec7nh gi\u1edbi h\u1ea1n<\/td><td>\u0110\u1eb7t gi\u00e1 mua t\u1ed1i \u0111a \u0111\u1ec3 tr\u00e1nh tr\u1ea3 qu\u00e1 cao<\/td><\/tr> <tr><td>5<\/td><td>Gi\u00e1m s\u00e1t v\u1ecb th\u1ebf c\u1ee7a b\u1ea1n<\/td><td>Theo d\u00f5i ng\u00e0y c\u00f4ng b\u1ed1 l\u1ee3i nhu\u1eadn v\u00e0 c\u00e1c c\u1ed9t m\u1ed1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi mu\u1ed1n th\u1eed s\u1ee9c \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n g\u1eedi t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong>\u2014ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c m\u00e0 kh\u00f4ng r\u1ee7i ro l\u1edbn<\/li> <li><strong>X\u00e1c minh nhanh nh\u01b0 ch\u1edbp<\/strong> ch\u1ec9 v\u1edbi m\u1ed9t gi\u1ea5y t\u1edd duy nh\u1ea5t<\/li> <li><strong>H\u00e0ng tr\u0103m ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed v\u00e0 v\u00ed \u0111i\u1ec7n t\u1eed<\/li> <li><strong>N\u1ec1n t\u1ea3ng th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng<\/strong> gi\u00fap \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ph\u1ee9c t\u1ea1p tr\u1edf n\u00ean d\u1ec5 ti\u1ebfp c\u1eadn<\/li> <\/ul> <p>R\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p c\u1ee7a n\u1ec1n t\u1ea3ng l\u00e0m cho n\u00f3 l\u00fd t\u01b0\u1edfng cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 mu\u1ed1n ti\u1ebfp c\u1eadn c\u00e1c c\u1ed5 phi\u1ebfu ti\u1ec1m n\u0103ng cao nh\u01b0 KROS m\u00e0 kh\u00f4ng c\u1ea7n cam k\u1ebft s\u1ed1 ti\u1ec1n l\u1edbn ban \u0111\u1ea7u.<\/p> <h2>\ud83c\udf0d Keros Therapeutics N\u0103m 2025: Khoa H\u1ecdc \u0110\u1eb1ng Sau C\u1ed5 Phi\u1ebfu<\/h2> <p>Keros Therapeutics kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u00f4ng th\u01b0\u1eddng\u2014h\u1ecd ti\u00ean phong trong vi\u1ec7c \u0111i\u1ec1u tr\u1ecb m\u1ed9t s\u1ed1 r\u1ed1i lo\u1ea1n y h\u1ecdc kh\u00f3 kh\u0103n nh\u1ea5t. T\u1eadp trung v\u00e0o c\u00e1c con \u0111\u01b0\u1eddng t\u00edn hi\u1ec7u TGF-\u03b2, h\u1ecd \u0111ang gi\u1ea3i quy\u1ebft c\u00e1c b\u1ec7nh huy\u1ebft h\u1ecdc hi\u1ebfm g\u1eb7p \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn s\u1ea3n xu\u1ea5t t\u1ebf b\u00e0o m\u00e1u.<\/p> <p>\u1ee8ng vi\u00ean h\u00e0ng \u0111\u1ea7u c\u1ee7a c\u00f4ng ty, KER-050, nh\u1eb1m gi\u00fap b\u1ec7nh nh\u00e2n m\u1eafc h\u1ed9i ch\u1ee9ng r\u1ed1i lo\u1ea1n t\u1ee7y x\u01b0\u01a1ng\u2014m\u1ed9t nh\u00f3m b\u1ec7nh m\u00e0 t\u1ee7y x\u01b0\u01a1ng kh\u00f4ng s\u1ea3n xu\u1ea5t \u0111\u1ee7 t\u1ebf b\u00e0o m\u00e1u kh\u1ecfe m\u1ea1nh. Ph\u01b0\u01a1ng ph\u00e1p c\u1ee7a h\u1ecd \u0111\u1ea1i di\u1ec7n cho m\u1ed9t c\u00e1ch ti\u1ebfp c\u1eadn ho\u00e0n to\u00e0n kh\u00e1c bi\u1ec7t so v\u1edbi c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb truy\u1ec1n th\u1ed1ng.<\/p> <p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025<\/strong>: Ph\u00f2ng th\u00ed nghi\u1ec7m nghi\u00ean c\u1ee9u c\u1ee7a Keros t\u1ea1i Lexington c\u00f3 thi\u1ebft b\u1ecb nh\u1ea1y c\u1ea3m \u0111\u1ebfn m\u1ee9c c\u00e1c nh\u00e0 nghi\u00ean c\u1ee9u ph\u1ea3i tr\u00e1nh s\u1eed d\u1ee5ng n\u01b0\u1edbc hoa ho\u1eb7c n\u01b0\u1edbc th\u01a1m m\u1ea1nh\u2014c\u00e1c ph\u00e2n t\u1eed m\u00f9i c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn k\u1ebft qu\u1ea3 th\u00ed nghi\u1ec7m!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Keros Therapeutics: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 30 th\u00e1ng 8 n\u0103m 2025, Keros Therapeutics, Inc. (KROS) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>15,48 USD<\/strong>\u2014m\u1ee9c gi\u00e1 \u0111\u00e3 thu h\u00fat s\u1ef1 ch\u00fa \u00fd c\u1ee7a c\u1ea3 nh\u1eefng nh\u00e0 s\u0103n gi\u00e1 tr\u1ecb v\u00e0 nh\u00e0 \u0111\u1ea7u t\u01b0 t\u0103ng tr\u01b0\u1edfng. Nh\u01b0ng h\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: <strong>Ng\u00e0y 5 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 v\u00f4 c\u00f9ng quan tr\u1ecdng. \u0110\u00f3 l\u00e0 khi Keros c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3, v\u00e0 theo l\u1ecbch s\u1eed, c\u00e1c b\u00e1o c\u00e1o n\u00e0y \u0111\u00e3 t\u1ea1o ra nh\u1eefng bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3.<\/p>\n<h3>C\u00e1ch B\u00e1o C\u00e1o L\u1ee3i Nhu\u1eadn \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu KROS<\/h3>\n<p>H\u00e3y \u0111\u1ec3 t\u00f4i cho b\u1ea1n th\u1ea5y t\u1ea1i sao l\u1ee3i nhu\u1eadn l\u1ea1i quan tr\u1ecdng \u0111\u1ebfn v\u1eady \u0111\u1ed1i v\u1edbi c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc nh\u01b0 KROS:<\/p>\n<table>\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th>\n<th>Thay \u0110\u1ed5i Sau Tin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>6 th\u00e1ng 8, 2025<\/td>\n<td>L\u1ee3i nhu\u1eadn qu\u00fd 2<\/td>\n<td>14,32 USD<\/td>\n<td>+8,1% (v\u01b0\u1ee3t d\u1ef1 b\u00e1o EPS)<\/td>\n<\/tr>\n<tr>\n<td>7 th\u00e1ng 5, 2025<\/td>\n<td>K\u1ebft qu\u1ea3 qu\u00fd 1<\/td>\n<td>16,50 USD<\/td>\n<td>-12,3% (doanh thu th\u1ea5p h\u01a1n d\u1ef1 ki\u1ebfn)<\/td>\n<\/tr>\n<tr>\n<td>12 th\u00e1ng 2, 2025<\/td>\n<td>B\u00e1o c\u00e1o h\u00e0ng n\u0103m<\/td>\n<td>18,75 USD<\/td>\n<td>+4,2% (ti\u1ebfn tri\u1ec3n trong pipeline)<\/td>\n<\/tr>\n<tr>\n<td>5 th\u00e1ng 11, 2024<\/td>\n<td>Qu\u00fd 3 n\u0103m 2024<\/td>\n<td>20,10 USD<\/td>\n<td>-6,8% (tr\u00ec ho\u00e3n l\u00e2m s\u00e0ng)<\/td>\n<\/tr>\n<tr>\n<td>8 th\u00e1ng 8, 2024<\/td>\n<td>Qu\u00fd 2 n\u0103m 2024<\/td>\n<td>22,40 USD<\/td>\n<td>+3,1% (d\u1eef li\u1ec7u th\u1eed nghi\u1ec7m t\u00edch c\u1ef1c)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Nh\u1eadn \u0110\u1ecbnh Xu H\u01b0\u1edbng<\/strong>: C\u1ed5 phi\u1ebfu Keros ph\u1ea3n \u1ee9ng m\u1ea1nh m\u1ebd v\u1edbi c\u00e1c c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 c\u00e1c c\u1ed9t m\u1ed1c quy \u0111\u1ecbnh. Nh\u1eefng b\u1ea5t ng\u1edd t\u00edch c\u1ef1c c\u00f3 th\u1ec3 k\u00edch ho\u1ea1t bi\u1ebfn \u0111\u1ed9ng 15-20% qua \u0111\u00eam, trong khi th\u1ea5t v\u1ecdng th\u01b0\u1eddng g\u00e2y ra \u0111i\u1ec1u ch\u1ec9nh m\u1ea1nh. \u0110i\u1ec1u then ch\u1ed1t l\u00e0 hi\u1ec3u r\u1eb1ng \u0111\u00e2y kh\u00f4ng ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu blue-chip th\u00f4ng th\u01b0\u1eddng\u2014\u0111\u00e2y l\u00e0 m\u1ed9t tr\u00f2 ch\u01a1i r\u1ee7i ro cao, ph\u1ea7n th\u01b0\u1edfng cao d\u1ef1a tr\u00ean \u0111\u1ed5i m\u1edbi y h\u1ecdc.<\/p>\n<h3>H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 3 &#8211; Th\u00e1ng 8 n\u0103m 2025)<\/h3>\n<p>C\u1ed5 phi\u1ebfu Keros \u0111\u00e3 tr\u1ea3i qua m\u1ed9t chuy\u1ebfn t\u00e0u l\u01b0\u1ee3n si\u00eau t\u1ed1c:<\/p>\n<p><strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: 18,20 USD (l\u1ea1c quan sau qu\u00fd 1)<br \/> <strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: 16,80 USD (th\u1ecb tr\u01b0\u1eddng chung \u0111i\u1ec1u ch\u1ec9nh)<br \/> <strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: 14,50 USD (doanh thu qu\u00fd 1 th\u1ea5p h\u01a1n k\u1ef3 v\u1ecdng)<br \/> <strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: 13,25 USD (lo ng\u1ea1i v\u1ec1 ho\u00e0n v\u1ed1n v\u1ed1n)<br \/> <strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: 15,10 USD (t\u0103ng nh\u1edd kh\u1edfi \u0111\u1ed9ng th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 3)<br \/> <strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: 15,48 USD (v\u01b0\u1ee3t l\u1ee3i nhu\u1eadn qu\u00fd 2)<\/p>\n<p>C\u1ed5 phi\u1ebfu \u0111\u00e3 gi\u1ea3m kho\u1ea3ng <strong>15%<\/strong> trong giai \u0111o\u1ea1n n\u00e0y nh\u01b0ng \u0111\u00e3 cho th\u1ea5y d\u1ea5u hi\u1ec7u \u1ed5n \u0111\u1ecbnh trong v\u00e0i tu\u1ea7n g\u1ea7n \u0111\u00e2y. T\u1ea1i sao l\u1ea1i bi\u1ebfn \u0111\u1ed9ng nh\u01b0 v\u1eady? Keros ho\u1ea1t \u0111\u1ed9ng trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1ed1n r\u1ea5t kh\u00f3 \u0111o\u00e1n, n\u01a1i k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng c\u00f3 th\u1ec3 l\u00e0m thay \u0111\u1ed5i gi\u00e1 tr\u1ecb c\u00f4ng ty ch\u1ec9 sau m\u1ed9t \u0111\u00eam.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 ti\u1ebfn tri\u1ec3n l\u00e2m s\u00e0ng, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 mang l\u1ea1i:<\/p>\n<p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 22-28 USD (ch\u1edd k\u1ebft qu\u1ea3 qu\u00fd 3 v\u00e0 c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m) \u2192 <strong>MUA<\/strong><br \/> <strong>2026<\/strong>: 35-45 USD (c\u00f3 th\u1ec3 n\u1ed9p h\u1ed3 s\u01a1 FDA cho c\u00e1c \u1ee9ng vi\u00ean h\u00e0ng \u0111\u1ea7u)<br \/> <strong>2028<\/strong>: 60-80 USD (giai \u0111o\u1ea1n th\u01b0\u01a1ng m\u1ea1i h\u00f3a n\u1ebfu \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t)<br \/> <strong>2030<\/strong>: Tr\u00ean 100 USD (th\u01b0\u01a1ng hi\u1ec7u b\u1ec7nh hi\u1ebfm \u0111\u00e3 \u0111\u01b0\u1ee3c thi\u1ebft l\u1eadp)<\/p>\n<p><strong>K\u1ebft lu\u1eadn<\/strong>: \u0110\u00e2y l\u00e0 m\u1ed9t <strong>mua mang t\u00ednh \u0111\u1ea7u c\u01a1<\/strong> d\u00e0nh cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu \u0111\u01b0\u1ee3c r\u1ee7i ro. Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng r\u1ea5t l\u1edbn n\u1ebfu c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng th\u00e0nh c\u00f4ng, nh\u01b0ng c\u0169ng c\u00f3 r\u1ee7i ro th\u1ea5t b\u1ea1i \u0111\u00e1ng k\u1ec3. Ch\u1ec9 n\u00ean \u0111\u1ea7u t\u01b0 s\u1ed1 ti\u1ec1n b\u1ea1n c\u00f3 th\u1ec3 ch\u1ea5p nh\u1eadn m\u1ea5t.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3>\n<ul>\n<li><strong>Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: R\u1ee7i ro l\u1edbn nh\u1ea5t\u2014th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 3 c\u00f3 th\u1ec3 cho th\u1ea5y hi\u1ec7u qu\u1ea3 kh\u00f4ng \u0111\u1ee7 ho\u1eb7c v\u1ea5n \u0111\u1ec1 an to\u00e0n. C\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc c\u00f3 th\u1ec3 gi\u1ea3m 50-80% khi c\u00f3 k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m ti\u00eau c\u1ef1c.<\/li>\n<li><strong>R\u00e0o c\u1ea3n quy \u0111\u1ecbnh<\/strong>: FDA t\u1eeb ch\u1ed1i ho\u1eb7c y\u00eau c\u1ea7u th\u00eam nghi\u00ean c\u1ee9u c\u00f3 th\u1ec3 tr\u00ec ho\u00e3n th\u01b0\u01a1ng m\u1ea1i h\u00f3a nhi\u1ec1u n\u0103m.<\/li>\n<li><strong>Ti\u00eau ti\u1ec1n m\u1eb7t<\/strong>: M\u1eb7c d\u00f9 \u0111\u00e3 ho\u00e0n v\u1ed1n g\u1ea7n \u0111\u00e2y, Keros v\u1eabn ti\u00eau ti\u1ec1n \u0111\u1ec3 ph\u00e1t tri\u1ec3n pipeline. H\u1ecd c\u00f3 th\u1ec3 c\u1ea7n c\u00e1c v\u00f2ng g\u1ecdi v\u1ed1n b\u1ed5 sung.<\/li>\n<li><strong>C\u1ea1nh tranh<\/strong>: C\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn h\u01a1n \u0111ang ph\u00e1t tri\u1ec3n c\u00e1c ch\u1ea5t \u1ee9c ch\u1ebf TGF-\u03b2 t\u01b0\u01a1ng t\u1ef1 c\u00f3 th\u1ec3 ra th\u1ecb tr\u01b0\u1eddng tr\u01b0\u1edbc.<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3>\n<ul>\n<li><strong>Chuy\u1ec3n m\u00ecnh ngo\u1ea1n m\u1ee5c<\/strong>: Keros b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn r\u00f2ng <strong>148,5 tri\u1ec7u USD<\/strong> trong qu\u00fd 1 n\u0103m 2025 so v\u1edbi <strong>l\u1ed7 43,1 tri\u1ec7u USD<\/strong> trong qu\u00fd 1 n\u0103m 2024\u2014m\u1ed9t s\u1ef1 chuy\u1ec3n \u0111\u1ed5i t\u00e0i ch\u00ednh ho\u00e0n to\u00e0n (<a href=\"https:\/\/www.marketbeat.com\/earnings\/reports\/2025-8-6-keros-therapeutics-inc-stock\/\">B\u00e1o c\u00e1o L\u1ee3i nhu\u1eadn Qu\u00fd 2<\/a>).<\/li>\n<li><strong>Ti\u1ebfn tri\u1ec3n giai \u0111o\u1ea1n 3<\/strong>: Vi\u1ec7c kh\u1edfi \u0111\u1ed9ng th\u1eed nghi\u1ec7m RENEW cho th\u1ea5y c\u00f4ng ty \u0111ang th\u1ef1c hi\u1ec7n \u0111\u00fang ti\u1ebfn \u0111\u1ed9 ph\u00e1t tri\u1ec3n.<\/li>\n<li><strong>Ch\u1ec9 \u0111\u1ecbnh thu\u1ed1c m\u1ed3 c\u00f4i<\/strong>: KER-065 nh\u1eadn \u0111\u01b0\u1ee3c tr\u1ea1ng th\u00e1i qu\u00fd gi\u00e1 n\u00e0y cho b\u1ec7nh lo\u1ea1n d\u01b0\u1ee1ng c\u01a1 Duchenne, mang l\u1ea1i \u0111\u1ed9c quy\u1ec1n th\u1ecb tr\u01b0\u1eddng v\u00e0 l\u1ee3i \u00edch t\u00e0i ch\u00ednh.<\/li>\n<li><strong>Ni\u1ec1m tin c\u1ee7a nh\u00e0 ph\u00e2n t\u00edch<\/strong>: M\u1eb7c d\u00f9 bi\u1ebfn \u0111\u1ed9ng g\u1ea7n \u0111\u00e2y, m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh l\u00e0 <strong>30,00 USD<\/strong>\u2014g\u1ea7n g\u1ea5p \u0111\u00f4i gi\u00e1 hi\u1ec7n t\u1ea1i (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/KROS\/forecast\/\">D\u1ef1 b\u00e1o c\u1ee7a Nh\u00e0 ph\u00e2n t\u00edch<\/a>).<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 2-3% danh m\u1ee5c \u0111\u1ea7u t\u01b0 cho KROS. \u0110\u00e2y kh\u00f4ng ph\u1ea3i l\u00e0 t\u00ecnh hu\u1ed1ng &#8220;\u0111\u1eb7t c\u01b0\u1ee3c t\u1ea5t c\u1ea3&#8221;.<\/li>\n<li><strong>Trung b\u00ecnh gi\u00e1 theo th\u1eddi gian<\/strong>: Thay v\u00ec mua m\u1ed9t l\u1ea7n, h\u00e3y chia nh\u1ecf c\u00e1c l\u1ea7n mua trong v\u00e0i th\u00e1ng \u0111\u1ec3 gi\u1ea3m r\u1ee7i ro th\u1eddi \u0111i\u1ec3m.<\/li>\n<li><strong>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7<\/strong>: B\u1ea3o v\u1ec7 b\u1ea3n th\u00e2n v\u1edbi m\u1ee9c d\u1eebng l\u1ed7 15-20% trong tr\u01b0\u1eddng h\u1ee3p th\u1eed nghi\u1ec7m kh\u00f4ng nh\u01b0 \u00fd.<\/li>\n<li><strong>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc<\/strong>: &#8220;Giao d\u1ecbch KROS gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba\u2014r\u1ea5t th\u00fa v\u1ecb khi m\u1ecdi th\u1ee9 su\u00f4n s\u1ebb, nh\u01b0ng h\u00e3y chu\u1ea9n b\u1ecb cho nh\u1eefng v\u1ee5 n\u1ed5 b\u1ea5t ng\u1edd trong ph\u00f2ng th\u00ed nghi\u1ec7m!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Keros Therapeutics, Inc. (KROS) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng c\u00f3 truy c\u1eadp NASDAQ v\u00e0 ph\u00ed hoa h\u1ed3ng h\u1ee3p l\u00fd<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>M\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Nghi\u00ean c\u1ee9u gi\u00e1 hi\u1ec7n t\u1ea1i<\/td>\n<td>Ki\u1ec3m tra gi\u00e1 th\u1eddi gian th\u1ef1c l\u00e0 15,48 USD (t\u00ednh \u0111\u1ebfn 30\/8\/2025)<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>\u0110\u1eb7t l\u1ec7nh gi\u1edbi h\u1ea1n<\/td>\n<td>\u0110\u1eb7t gi\u00e1 mua t\u1ed1i \u0111a \u0111\u1ec3 tr\u00e1nh tr\u1ea3 qu\u00e1 cao<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Gi\u00e1m s\u00e1t v\u1ecb th\u1ebf c\u1ee7a b\u1ea1n<\/td>\n<td>Theo d\u00f5i ng\u00e0y c\u00f4ng b\u1ed1 l\u1ee3i nhu\u1eadn v\u00e0 c\u00e1c c\u1ed9t m\u1ed1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi mu\u1ed1n th\u1eed s\u1ee9c \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n g\u1eedi t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong>\u2014ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c m\u00e0 kh\u00f4ng r\u1ee7i ro l\u1edbn<\/li>\n<li><strong>X\u00e1c minh nhanh nh\u01b0 ch\u1edbp<\/strong> ch\u1ec9 v\u1edbi m\u1ed9t gi\u1ea5y t\u1edd duy nh\u1ea5t<\/li>\n<li><strong>H\u00e0ng tr\u0103m ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed v\u00e0 v\u00ed \u0111i\u1ec7n t\u1eed<\/li>\n<li><strong>N\u1ec1n t\u1ea3ng th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng<\/strong> gi\u00fap \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ph\u1ee9c t\u1ea1p tr\u1edf n\u00ean d\u1ec5 ti\u1ebfp c\u1eadn<\/li>\n<\/ul>\n<p>R\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p c\u1ee7a n\u1ec1n t\u1ea3ng l\u00e0m cho n\u00f3 l\u00fd t\u01b0\u1edfng cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 mu\u1ed1n ti\u1ebfp c\u1eadn c\u00e1c c\u1ed5 phi\u1ebfu ti\u1ec1m n\u0103ng cao nh\u01b0 KROS m\u00e0 kh\u00f4ng c\u1ea7n cam k\u1ebft s\u1ed1 ti\u1ec1n l\u1edbn ban \u0111\u1ea7u.<\/p>\n<h2>\ud83c\udf0d Keros Therapeutics N\u0103m 2025: Khoa H\u1ecdc \u0110\u1eb1ng Sau C\u1ed5 Phi\u1ebfu<\/h2>\n<p>Keros Therapeutics kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u00f4ng th\u01b0\u1eddng\u2014h\u1ecd ti\u00ean phong trong vi\u1ec7c \u0111i\u1ec1u tr\u1ecb m\u1ed9t s\u1ed1 r\u1ed1i lo\u1ea1n y h\u1ecdc kh\u00f3 kh\u0103n nh\u1ea5t. T\u1eadp trung v\u00e0o c\u00e1c con \u0111\u01b0\u1eddng t\u00edn hi\u1ec7u TGF-\u03b2, h\u1ecd \u0111ang gi\u1ea3i quy\u1ebft c\u00e1c b\u1ec7nh huy\u1ebft h\u1ecdc hi\u1ebfm g\u1eb7p \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn s\u1ea3n xu\u1ea5t t\u1ebf b\u00e0o m\u00e1u.<\/p>\n<p>\u1ee8ng vi\u00ean h\u00e0ng \u0111\u1ea7u c\u1ee7a c\u00f4ng ty, KER-050, nh\u1eb1m gi\u00fap b\u1ec7nh nh\u00e2n m\u1eafc h\u1ed9i ch\u1ee9ng r\u1ed1i lo\u1ea1n t\u1ee7y x\u01b0\u01a1ng\u2014m\u1ed9t nh\u00f3m b\u1ec7nh m\u00e0 t\u1ee7y x\u01b0\u01a1ng kh\u00f4ng s\u1ea3n xu\u1ea5t \u0111\u1ee7 t\u1ebf b\u00e0o m\u00e1u kh\u1ecfe m\u1ea1nh. Ph\u01b0\u01a1ng ph\u00e1p c\u1ee7a h\u1ecd \u0111\u1ea1i di\u1ec7n cho m\u1ed9t c\u00e1ch ti\u1ebfp c\u1eadn ho\u00e0n to\u00e0n kh\u00e1c bi\u1ec7t so v\u1edbi c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb truy\u1ec1n th\u1ed1ng.<\/p>\n<p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025<\/strong>: Ph\u00f2ng th\u00ed nghi\u1ec7m nghi\u00ean c\u1ee9u c\u1ee7a Keros t\u1ea1i Lexington c\u00f3 thi\u1ebft b\u1ecb nh\u1ea1y c\u1ea3m \u0111\u1ebfn m\u1ee9c c\u00e1c nh\u00e0 nghi\u00ean c\u1ee9u ph\u1ea3i tr\u00e1nh s\u1eed d\u1ee5ng n\u01b0\u1edbc hoa ho\u1eb7c n\u01b0\u1edbc th\u01a1m m\u1ea1nh\u2014c\u00e1c ph\u00e2n t\u1eed m\u00f9i c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn k\u1ebft qu\u1ea3 th\u00ed nghi\u1ec7m!<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu Keros Therapeutics (KROS)?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch c\u00f3 truy c\u1eadp NASDAQ, m\u1edf t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, ki\u1ec3m tra gi\u00e1 hi\u1ec7n t\u1ea1i, \u0111\u1eb7t l\u1ec7nh gi\u1edbi h\u1ea1n v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a m\u00ecnh."},{"question":"Keros Therapeutics c\u00f3 r\u1ee7i ro g\u00ec khi \u0111\u1ea7u t\u01b0?","answer":"R\u1ee7i ro ch\u00ednh bao g\u1ed3m th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, r\u00e0o c\u1ea3n quy \u0111\u1ecbnh, ti\u00eau ti\u1ec1n m\u1eb7t nhanh v\u00e0 c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a KROS trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 c\u00f3 th\u1ec3 t\u0103ng l\u00ean 22-28 USD v\u00e0o cu\u1ed1i n\u0103m 2025, 35-45 USD n\u0103m 2026, 60-80 USD n\u0103m 2028 v\u00e0 tr\u00ean 100 USD v\u00e0o n\u0103m 2030 n\u1ebfu c\u00e1c th\u1eed nghi\u1ec7m th\u00e0nh c\u00f4ng v\u00e0 \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t."},{"question":"Nh\u1eefng t\u00edn hi\u1ec7u t\u00edch c\u1ef1c n\u00e0o cho Keros Therapeutics n\u0103m 2025?","answer":"Keros \u0111\u00e3 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn r\u00f2ng l\u1edbn, ti\u1ebfn tri\u1ec3n th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 3, nh\u1eadn ch\u1ec9 \u0111\u1ecbnh thu\u1ed1c m\u1ed3 c\u00f4i v\u00e0 \u0111\u01b0\u1ee3c c\u00e1c nh\u00e0 ph\u00e2n t\u00edch \u0111\u00e1nh gi\u00e1 cao v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 g\u1ea7n g\u1ea5p \u0111\u00f4i hi\u1ec7n t\u1ea1i."},{"question":"L\u1eddi khuy\u00ean cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi khi mua c\u1ed5 phi\u1ebfu KROS l\u00e0 g\u00ec?","answer":"B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf, \u00e1p d\u1ee5ng trung b\u00ecnh gi\u00e1 theo th\u1eddi gian, \u0111\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7 v\u00e0 hi\u1ec3u r\u1eb1ng \u0111\u00e2y l\u00e0 kho\u1ea3n \u0111\u1ea7u t\u01b0 r\u1ee7i ro cao."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu Keros Therapeutics (KROS)?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch c\u00f3 truy c\u1eadp NASDAQ, m\u1edf t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, ki\u1ec3m tra gi\u00e1 hi\u1ec7n t\u1ea1i, \u0111\u1eb7t l\u1ec7nh gi\u1edbi h\u1ea1n v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a m\u00ecnh."},{"question":"Keros Therapeutics c\u00f3 r\u1ee7i ro g\u00ec khi \u0111\u1ea7u t\u01b0?","answer":"R\u1ee7i ro ch\u00ednh bao g\u1ed3m th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, r\u00e0o c\u1ea3n quy \u0111\u1ecbnh, ti\u00eau ti\u1ec1n m\u1eb7t nhanh v\u00e0 c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a KROS trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 c\u00f3 th\u1ec3 t\u0103ng l\u00ean 22-28 USD v\u00e0o cu\u1ed1i n\u0103m 2025, 35-45 USD n\u0103m 2026, 60-80 USD n\u0103m 2028 v\u00e0 tr\u00ean 100 USD v\u00e0o n\u0103m 2030 n\u1ebfu c\u00e1c th\u1eed nghi\u1ec7m th\u00e0nh c\u00f4ng v\u00e0 \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t."},{"question":"Nh\u1eefng t\u00edn hi\u1ec7u t\u00edch c\u1ef1c n\u00e0o cho Keros Therapeutics n\u0103m 2025?","answer":"Keros \u0111\u00e3 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn r\u00f2ng l\u1edbn, ti\u1ebfn tri\u1ec3n th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 3, nh\u1eadn ch\u1ec9 \u0111\u1ecbnh thu\u1ed1c m\u1ed3 c\u00f4i v\u00e0 \u0111\u01b0\u1ee3c c\u00e1c nh\u00e0 ph\u00e2n t\u00edch \u0111\u00e1nh gi\u00e1 cao v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 g\u1ea7n g\u1ea5p \u0111\u00f4i hi\u1ec7n t\u1ea1i."},{"question":"L\u1eddi khuy\u00ean cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi khi mua c\u1ed5 phi\u1ebfu KROS l\u00e0 g\u00ec?","answer":"B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf, \u00e1p d\u1ee5ng trung b\u00ecnh gi\u00e1 theo th\u1eddi gian, \u0111\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7 v\u00e0 hi\u1ec3u r\u1eb1ng \u0111\u00e2y l\u00e0 kho\u1ea3n \u0111\u1ea7u t\u01b0 r\u1ee7i ro cao."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-30T14:06:13+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS)\",\"datePublished\":\"2025-08-30T14:06:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"datePublished\":\"2025-08-30T14:06:13+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-30T14:06:13+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS)","datePublished":"2025-08-30T14:06:13+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","datePublished":"2025-08-30T14:06:13+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-keros-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Keros Therapeutics, Inc. (KROS)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":360336,"slug":"how-to-buy-keros-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Keros Therapeutics, Inc. (KROS) - Investimento em a\u00e7\u00f5es da Keros Therapeutics, Inc. (KROS)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-keros-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/360339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=360339"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/360339\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334036"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=360339"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=360339"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=360339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}